Aklog Lishan has filed 4 insider transactions across 2 companies since May 2024.
Most recent transaction: a grant/award of 2170000 shares of Lucid Diagnostics Inc. ($LUCD) on February 20, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 20, 2026 | Lucid Diagnostics Inc. | $LUCD | Aklog Lishan | Chief Executive Officer | A | Common Stock | 2170000 | $0.00 | 3,636,627.0000 | 137,683,002 | 147.96% | 1.58% |
| Sept. 30, 2025 | PAVmed Inc. | $PAVM | Aklog Lishan | Chairman and CEO | A | Common Stock | 150000 | $0.00 | 527,162.0000 | 65,291,623 | 39.77% | 0.23% |
| Feb. 20, 2025 | Lucid Diagnostics Inc. | $LUCD | Aklog Lishan | Chief Executive Officer | A | Common Stock | 300000 | $0.00 | 1,466,627.0000 | 66,969,390 | 25.72% | 0.45% |
| May 7, 2024 | Lucid Diagnostics Inc. | $LUCD | Aklog Lishan | Chief Executive Officer | A | Common stock | 400000 | $0.00 | 1,166,627.0000 | 0 | 52.18% | 0.00% |